CD8A and infection: In contrast, the participants who experienced post-ART viral control after receiving 3BNC117 at ART initiation were approximately equally distributed amongst those with “recent” (< 6 months) and “long-term” (> 6 months) infection and all had detectable HIV-specific CD8+ T cells [7].